NAD+ 1G & RETATRUTIDE : A UNITED KINGDOM UPDATE

The growing interest in NAD+ supplementation, particularly at a significant dosage of 1g , continues to gain momentum within the British medical community. At the same time , attention is directed toward Retatrutide, a groundbreaking GLP-1 medication being viewed by many as a potential advancemen